NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
Back to search
Official data from USPTO
RASZA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RASZA THERAPEUTICS
ST13
US500000098517933Class
44
Filing
98517933
Registration
8007643
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/04/2025
Trademark type
Word
Nice classes
44
Filing date
04/24/2024
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/01/2024
First use in commerce
09/01/2024
Drawing code
4
Owner type
99
Owner location
Laguna Beach, CA
Examiner
DUONG, ANGELA GAW
Law office
O30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rasza Therapeutics, Inc.
Representatives
Gregory N. Brescia Gordon & Rees LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Mental health services; Medical treatment of mental health disorders and psychotherapeutic treatment; consulting services in the nature of mental health and wellnessproviding of expertise and opinions for medicalpsychological and psychotherapeutic topics and treatments.
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBO
PUBLISHED FOR OPPOSITION
09/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2025
IUAA
USE AMENDMENT ACCEPTED
08/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/17/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/17/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2025
GNRT
NON-FINAL ACTION E-MAILED
03/20/2025
CNRT
NON-FINAL ACTION WRITTEN
03/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2025
DOCK
ASSIGNED TO EXAMINER
02/03/2025
DOCK
ASSIGNED TO EXAMINER
11/22/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/19/2024
IUAF
USE AMENDMENT FILED
11/19/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2024
GNRT
NON-FINAL ACTION E-MAILED
11/18/2024
CNRT
NON-FINAL ACTION WRITTEN
11/18/2024
DOCK
ASSIGNED TO EXAMINER
11/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2024
NWAP
NEW APPLICATION ENTERED
04/24/2024
Continuous trademark protection
Get notified about every new filing that threatens RASZA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.